tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MBRX Stock Latest News

Moleculin Biotech Announces Promising Annamycin Trial Results
Company AnnouncementsMoleculin Biotech Announces Promising Annamycin Trial Results
19d ago
8K
MBRX
Moleculin Biotech reports data from Phase 1B/2 (MB-106) clinical trial
PremiumThe Fly
Moleculin Biotech reports data from Phase 1B/2 (MB-106) clinical trial
19d ago
MBRX
Moleculin Biotech files $200M mixed securities shelf
PremiumThe Fly
Moleculin Biotech files $200M mixed securities shelf
25d ago
MBRX
Moleculin Biotech fiels $200M mixed securities shelf
PremiumThe Fly
Moleculin Biotech fiels $200M mixed securities shelf
25d ago
MBRX
Moleculin Biotech to Present Research at EHA2024 Hybrid Congress
PremiumCompany Announcements
Moleculin Biotech to Present Research at EHA2024 Hybrid Congress
2M ago
8K
MBRX
Moleculin Biotech Initiates Phase 2 Glioblastoma Treatment Study
PremiumCompany AnnouncementsMoleculin Biotech Initiates Phase 2 Glioblastoma Treatment Study
2M ago
8K
MBRX
Moleculin Biotech begins Phase 2 study evaluating WP1066
PremiumThe Fly
Moleculin Biotech begins Phase 2 study evaluating WP1066
2M ago
MBRX
Moleculin Biotech Updates Investors with Corporate Presentation
PremiumCompany Announcements
Moleculin Biotech Updates Investors with Corporate Presentation
2M ago
8K
MBRX
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
2M ago
MBRX
Moleculin Biotech reports Q1 EPS ($2.02) vs. ($4.13) last year
PremiumThe Fly
Moleculin Biotech reports Q1 EPS ($2.02) vs. ($4.13) last year
2M ago
MBRX
Moleculin Biotech Secures Patent for Liposomal Drug Innovation
PremiumCompany Announcements
Moleculin Biotech Secures Patent for Liposomal Drug Innovation
2M ago
8K
MBRX
Moleculin Biotech announces U.S. patent issue notification for Annamycin
PremiumThe Fly
Moleculin Biotech announces U.S. patent issue notification for Annamycin
2M ago
MBRX
Moleculin Biotech Announces Upcoming Quarterly Financial Results
PremiumCompany AnnouncementsMoleculin Biotech Announces Upcoming Quarterly Financial Results
2M ago
8K
MBRX
Moleculin Biotech Shares Corporate Update Online
PremiumCompany Announcements
Moleculin Biotech Shares Corporate Update Online
2M ago
8K
MBRX
Moleculin Biotech Shares Upbeat Annamycin AML Trial Update
PremiumCompany Announcements
Moleculin Biotech Shares Upbeat Annamycin AML Trial Update
2M ago
8K
MBRX
Moleculin Biotech reports interim data for Annamycin
PremiumThe Fly
Moleculin Biotech reports interim data for Annamycin
2M ago
MBRX
Moleculin Biotech Hosts AML Clinical Insights Virtual Event
PremiumCompany Announcements
Moleculin Biotech Hosts AML Clinical Insights Virtual Event
2M ago
8K
MBRX
Moleculin Biotech Shares Corporate Direction Insights
PremiumCompany Announcements
Moleculin Biotech Shares Corporate Direction Insights
2M ago
8K
MBRX
Moleculin Biotech’s Annamycin Granted Orphan Drug Status in EU
PremiumCompany Announcements
Moleculin Biotech’s Annamycin Granted Orphan Drug Status in EU
3M ago
8K
MBRX
Moleculin Biotech: EMA grants orphan drug designation to Annamycin
PremiumThe FlyMoleculin Biotech: EMA grants orphan drug designation to Annamycin
3M ago
MBRX
Moleculin Biotech Reveals Promising Annamycin Cancer Drug Data
PremiumCompany Announcements
Moleculin Biotech Reveals Promising Annamycin Cancer Drug Data
3M ago
8K
MBRX
Moleculin Biotech announces preclinical data regarding anthracycline
PremiumThe Fly
Moleculin Biotech announces preclinical data regarding anthracycline
3M ago
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >